PNC Financial Services Group
INMB icon

PNC Financial Services Group’s INmune Bio INMB Stock Holding History

PNC Financial Services Group’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.3K Buy
40,120
+2,315
+6% +$3.3K ﹤0.01% 3270
2025
Q4 		$59K Sell
37,805
-582
-2% -$1.04K ﹤0.01% 3117
2025
Q3 		$79.5K Buy
38,387
+672
+2% +$1.54K ﹤0.01% 2952
2025
Q2 		$87.1K Buy
+37,715
New +$277K ﹤0.01% 2802
2022
Q3 		– Sell
-820
Closed -$8K – 4528
2022
Q2 		$8K Buy
+820
New +$6.1K ﹤0.01% 3876

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PNC Financial Services Group's INMB Position: Q1 2026 in Review

PNC Financial Services Group increased its INmune Bio (INMB) stake by 6.1% in Q1 2026, buying an estimated $3.3K and bringing the position to 40,120 shares worth $45.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

PNC Financial Services Group first reported a position in INMB in Q2 2022 and has held it in 5 quarters since. The position peaked at $87.1K in Q2 2025. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • PNC Financial Services Group held 40,120 shares of INmune Bio worth $45.3K as of Q1 2026.
  • PNC Financial Services Group bought 2,315 INmune Bio shares in Q1 2026, an estimated $3.3K.
  • INmune Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3270 holding.
  • PNC Financial Services Group first reported a position in INmune Bio in Q2 2022 and has held it in 5 quarters since.
  • PNC Financial Services Group's INmune Bio position peaked at $87.1K in Q2 2025.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.